ny or All documents presenting and referring to the isolation of of the Sars Covid 2 / Covid 19 virus and sub strains as a independent biological viral entity at microscopic level.
Dear Therapeutic Goods Administration,
Please refer to my request for any official documents presenting the official information of the Sars 2/ Covid 19 virus. I specifically request the documents relating to the isolation of the Covid 19 virus and sub strains as presented to medical bodies for assessment in relation to any supposed vaccine and their benefits and/or side effects.
I specifically wish to see the Department of Health's records of independent research into an isolated form of Sars2 and/or Covid 19 and sub strains.
I specifically wish to see the Department of Healths independent documentation relating to the isolation of the Sars 2 / Covid 19 biological viral entity and the captured vision via electron microscope and/or any other method of capturing vision of the Covid 19 virus at molecular level.
I specifically wish to see documentation related to the assessment of the Covid 19 Viral biological entity in relation to the mandate of Covid 19 vaccines as recommended to Business and/or advice given to business seeking to mandate vaccines for workers.
Yours faithfully,
Matthew Peos
Dear Therapeutic Goods Administration,
Please pass this on to the person who conducts Freedom of Information reviews.
I am writing to request an internal review of Therapeutic Goods Administration's handling of my FOI request 'ny or All documents presenting and referring to the isolation of of the Sars Covid 2 / Covid 19 virus and sub strains as a independent biological viral entity at microscopic level.'.
The time frame for my documentation is long overdue according to law.
I now have concerns that the documentation requested does not exist and the attempts at delaying my request is infact a tactic in order to fabricate the necessary documents for publishing.
A full history of my FOI request and all correspondence is available on the Internet at this address: https://www.righttoknow.org.au/request/n...
Yours faithfully,
Matthew Peos
Good afternoon Mr Peos
Thank you for your two emails sent on 14 January 2022 in regards to two FOI requests with the Department of Health.
We note that you have requested an Internal Review of a decision issued on 1 December 2021 in relation to FOI-3149 (reference: [email address]).
We also note that you have requested a review of a second request sent to the Department of Health (addressed to the Therapeutic Goods Administration (TGA)), reference: [FOI #7914 email]. That request has a Department reference of FOI-3172. You have indicated in your request for a review that a decision in this request is overdue.
The TGA is part of the Department of Health. The decision issued to you on 1 December 2021 related to both FOI-3149 and FOI-3172. As such, the Department has two requests on hand, which are the similar or same in scope, and for which one decision on access was issued, on 1 December 2021.
The FOI Act provides a right for an applicant to seek an internal review of a decision within 30 days of the date of the decision. As such, your request for an internal review is currently outside the timeframe permitted by the Act. The Department, is however, agreeable to an extension to that timeframe, and to accept the request for internal review outside that timeframe. Could you please confirm that you would like the Department to extend the timeframe and proceed with your request for an internal review?
Alternatively, you have 60 days from the date of the decision being notified to you to request an external review by the Australian Information Commissioner.
Details of your rights in relation to the reviews are set out in the decision provided to you on 1 December 2021.
With kind regards
Alison
Freedom of Information Unit
Legal and Assurance Division | Corporate Operations Group
Legal Advice & Legislation Branch
Australian Government Department of Health
P: 02 6289 1666 E: [TGA request email]
GPO Box 9848, Canberra ACT 2601, Australia
The Department of Health acknowledges the Traditional Custodians of Australia and their continued connection to land, sea and community. We pay our respects to all Elders past and present.
Please note that this email and attachments may contain confidential or legally privileged information. Please consult with Legal Division before disclosing any part of this email, or attachment, outside the Department. If you receive this email in error, please delete it and contact the sender immediately
"Important: This transmission is intended only for the use of the addressee and may contain confidential or legally privileged information. If you are not the intended recipient, you are notified that any use or dissemination of this communication is strictly prohibited. If you receive this transmission in error please notify the author immediately and delete all copies of this transmission."
Good afternoon Mr Peos
Thank you for your two emails sent on 14 January 2022 in regards to two FOI requests with the Department of Health.
We note that you have requested an Internal Review of a decision issued on 1 December 2021 in relation to FOI-3149 (reference: [email address]).
We also note that you have requested a review of a second request sent to the Department of Health (addressed to the Therapeutic Goods Administration (TGA)), reference: [FOI #7914 email]. That request has a Department reference of FOI-3172. You have indicated in your request for a review that a decision in this request is overdue.
The TGA is part of the Department of Health. The decision issued to you on 1 December 2021 related to both FOI-3149 and FOI-3172. As such, the Department has two requests on hand, which are the similar or same in scope, and for which one decision on access was issued, on 1 December 2021.
The FOI Act provides a right for an applicant to seek an internal review of a decision within 30 days of the date of the decision. As such, your request for an internal review is currently outside the timeframe permitted by the Act. The Department, is however, agreeable to an extension to that timeframe, and to accept the request for internal review outside that timeframe. Could you please confirm that you would like the Department to extend the timeframe and proceed with your request for an internal review?
Alternatively, you have 60 days from the date of the decision being notified to you to request an external review by the Australian Information Commissioner.
Details of your rights in relation to the reviews are set out in the decision provided to you on 1 December 2021.
With kind regards
Alison
Freedom of Information Unit
Legal and Assurance Division | Corporate Operations Group
Legal Advice & Legislation Branch
Australian Government Department of Health
P: 02 6289 1666 E: [TGA request email]
GPO Box 9848, Canberra ACT 2601, Australia
The Department of Health acknowledges the Traditional Custodians of Australia and their continued connection to land, sea and community. We pay our respects to all Elders past and present.
Please note that this email and attachments may contain confidential or legally privileged information. Please consult with Legal Division before disclosing any part of this email, or attachment, outside the Department. If you receive this email in error, please delete it and contact the sender immediately
"Important: This transmission is intended only for the use of the addressee and may contain confidential or legally privileged information. If you are not the intended recipient, you are notified that any use or dissemination of this communication is strictly prohibited. If you receive this transmission in error please notify the author immediately and delete all copies of this transmission."
Dear Mr Peos
Please find attached correspondence from the department in relation to your internal review request.
Regards
Freedom of Information Section
Legal & Assurance Division | Corporate Operations Group
Legal Advice & Legislation Branch
Australian Government Department of Health
E: [TGA request email]
GPO Box 9848, Canberra ACT 2601, Australia
"Important: This transmission is intended only for the use of the addressee and may contain confidential or legally privileged information. If you are not the intended recipient, you are notified that any use or dissemination of this communication is strictly prohibited. If you receive this transmission in error please notify the author immediately and delete all copies of this transmission."